Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). DD Simpson, GW Joe, KM Broome, ML Hiller, K Knight, GA Rowan-Szal Psychology of Addictive Behaviors 11 (4), 279, 1997 | 1091* | 1997 |
Prison‐based substance abuse treatment, residential aftercare and recidivism ML Hiller, K Knight, DD Simpson Addiction 94 (6), 833-842, 1999 | 378 | 1999 |
Three-year reincarceration outcomes for in-prison therapeutic community treatment in Texas K Knight, DD Simpson, ML Hiller The Prison Journal 79 (3), 337-351, 1999 | 324 | 1999 |
Motivation as a predictor of therapeutic engagement in mandated residential substance abuse treatment ML Hiller, K Knight, C Leukefeld, DD Simpson Criminal Justice and Behavior 29 (1), 56-75, 2002 | 278 | 2002 |
Treating substance use disorders in the criminal justice system S Belenko, M Hiller, L Hamilton Current psychiatry reports 15, 1-11, 2013 | 242 | 2013 |
Predicting recidivism for released state prison offenders: Examining the influence of individual and neighborhood characteristics and spatial contagion on the likelihood of … GJ Stahler, J Mennis, S Belenko, WN Welsh, ML Hiller, G Zajac Criminal justice and behavior 40 (6), 690-711, 2013 | 213 | 2013 |
Gender differences at admission and follow-up in a sample of methadone maintenance clients LR Chatham, ML Hiller, GA Rowan-Szal, GW Joe, DD Simpson Substance use & misuse 34 (8), 1137-1165, 1999 | 209 | 1999 |
Risk factors that predict dropout from corrections-based treatment for drug abuse ML Hiller, K Knight, DD Simpson The Prison Journal 79 (4), 411-430, 1999 | 200 | 1999 |
Legal pressure and treatment retention in a national sample of long-term residential programs ML Hiller, K Knight, KM Broome, DD Simpson Criminal Justice and Behavior 25 (4), 463-481, 1998 | 195 | 1998 |
Legal pressure, treatment readiness, and engagement in long-term residential programs K Knight, ML Hiller, KM Broome, DD Simpson Journal of Offender Rehabilitation 31 (1-2), 101-115, 2000 | 169 | 2000 |
Drug treatment process indicators for probationers and prediction of recidivism KM Broome, K Knight, ML Hiller, DD Simpson Journal of Substance Abuse Treatment 13 (6), 487-491, 1996 | 163 | 1996 |
Peer, family, and motivational influences on drug treatment process and recidivism for probationers KM Broome, DK Knight, K Knight, ML Hiller, DD Simpson Journal of Clinical Psychology 53 (4), 387-397, 1997 | 155 | 1997 |
Screening and referral for substance-abuse treatment in the criminal justice system K Knight, DD Simpson, ML Hiller, C Leukefeld, F Tims, D Farabee Treatment of drug offenders: Policies and issues, 259-272, 2002 | 133 | 2002 |
A cost-effectiveness analysis of in-prison therapeutic community treatment and risk classification JD Griffith, ML Hiller, K Knight, DD Simpson The Prison Journal 79 (3), 352-368, 1999 | 129 | 1999 |
Problem severity and motivation for treatment in incarcerated substance abusers ML Hiller, E Narevic, JM Webster, P Rosen, M Staton, C Leukefeld, ... Substance Use & Misuse 44 (1), 28-41, 2009 | 103 | 2009 |
A model for rigorously applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework in the design and measurement of a large scale collaborative multi … JE Becan, JP Bartkowski, DK Knight, TRA Wiley, R DiClemente, ... Health & justice 6, 1-14, 2018 | 94 | 2018 |
Treatment motivation and therapeutic engagement in prison-based substance use treatment PJ Rosen, ML Hiller, JM Webster, M Staton, C Leukefeld Journal of psychoactive drugs 36 (3), 387-396, 2004 | 90 | 2004 |
Recidivism following mandated residential substance abuse treatment for felony probationers ML Hiller, K Knight, DD Simpson The Prison Journal 86 (2), 230-241, 2006 | 83 | 2006 |
Substance abuse among rural and very rural drug users at treatment entry ML Schoeneberger, CG Leukefeld, ML Hiller, T Godlaski The American Journal of Drug and Alcohol Abuse 32 (1), 87-110, 2006 | 81 | 2006 |
Head injury among drug abusers: an indicator of co-occurring problems R Walker, M Hiller, M Staton, CG Leukefeld Journal of Psychoactive Drugs 35 (3), 343-353, 2003 | 73 | 2003 |